Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Net Sales $ 8,003
Operating Expenses:    
Research and development 130,000 89,600
General and administrative 5,269,574 617,537
Total operating expenses (5,399,574) (707,137)
Loss from operations (5,391,571) (707,137)
Other income (expense)    
Change in fair value of derivative liability (2,624,887)
Debt extinguishment (1,067,242) (26,000)
Interest expense - amortization of debt discount (747,623) (39,678)
Interest expense (including $58,142 and $58,142 to related parties) (203,933) (84,005)
Financing costs (171,739)
Other expense (6,239)
Gain on extinguishment of derivative liability 1,718,816
Total other expense (3,102,847) (149,683)
Net loss $ (8,494,418) $ (856,820)
Loss per share - basic and diluted $ (0.07) $ (0.01)
Weighted average number of common shares outstanding - basic and diluted 127,358,921 95,882,696